Module

Management Update on Hepatitis/HIV Coinfection

Source: HIV/AIDS Annual Update 2006

Management Update on Hepatitis/HIV Coinfection

CME Program Director: John P. Phair, MD

Faculty:
Mark S. Sulkowski, MD

CME CREDIT INFORMATION

Release Date: 06/30/06

Expiration Date: 06/29/07

Physicians: maximum of 1.5 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.5 contact hours (0.15 CEUs)

Registered Nurses: 1.8 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe current approaches to treating hepatitis C virus (HCV) infection in patients with HIV
Discuss new therapeutics in development for treatment of HCV
Describe current approaches to treating hepatitis B virus (HBV) infection in patients with HIV

Topics covered include:

Introduction
Hepatitis C in the HIV-Infected Patient
Current HCV Treatments
Investigational HCV Treatments
Investigational Antiviral Therapy for HCV
Conclusions: HCV
Hepatitis B in the HIV-Infected Patient
HBV Treatment
Prevention of HBV Infection
Conclusions: HBV
Summary—Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.